What is metabolomics?
Metabolomics is the systematic study of small-molecule metabolites (typically <1.5 kDa) and provides the most immediate and sensitive readout of cellular physiology.
Metabolomics has been called "supra-omic" because it provides a real-time, functional snapshot of a cell's physiological state, reflecting perturbations that occur downstream of genomics, transcriptomics, and proteomics. While genomics describes what could happen and proteomics describes what machinery is available, metabolomics provides a real-time snapshot describing what is happening right now in the biochemical network.
Discordance between mRNA, protein, and metabolite levels is common due to translational control, enzyme kinetics, allosteric regulation, and substrate availability — factors that only metabolomics captures directly. In addition, metabolites are active regulators and not passive readouts, influencing transcription, RNA behaviour, enzyme activity, post-translational modification, and protein stability.
When is metabolomics most suitable?
Metabolomics is most suitable when the phenotype of interest is biochemical or functional — such as suspected changes in energy metabolism, redox balance, or specific metabolic pathways related to disease mechanisms or treatment response.
It is particularly valuable for biomarker discovery, where measurements should directly reflect physiological processes, and for integrative studies aiming to capture the combined impact of genetics, environment, microbiome, and other regulatory layers on the biochemical state.
Is metabolomics right for your study?
Metabolomics adds the most value when your research question involves a biochemical mechanism, a functional outcome, or a phenotype that genes alone cannot explain.
Multi-omics integration
Metabolomics integrates with genomics (GWAS + metabolomics), transcriptomics (gene expression + pathway activity), and proteomics (enzyme levels + metabolite flux). BeVital can advise on integration strategy for multi-omics study design.
Untargeted, semi-targeted, or targeted?
Selecting the most suitable approach depends on your research objectives and study hypothesis — whether you are generating new hypotheses or testing existing ones.
Untargeted
A hypothesis-generating approach that analyzes as many metabolites as possible without prior knowledge of their identity.
Best used for: Broad, comprehensive profiling and discovery of new or unexpected biomarkers.
Core focus: Global screening & exploratory discovery.
Semi-targeted
Focuses on a predefined subset of metabolites often from a specific biological pathway or chemical class but without strict, absolute quantification.
Best used for: Combining a high level of metabolite selection with exploratory analysis
Core focus: Pathway screening & relative quantification.
Targeted
Specifically measures and quantifies a predefined set of known metabolites with extreme accuracy. It is highly sensitive, precise, and optimized for rigorous verification.
Best used for: Hypothesis-driven research or validation of known metabolic pathways.
Core focus: Absolute quantification & peer-reviewed validation.
Why targeted surpasses untargeted for data quality — verbatim key passage
Untargeted metabolomics provides relative quantification, limiting the ability to compare data across different experiments, labs, cohorts, or studies. In contrast, targeted metabolomics delivers absolute quantification (typically in nmol/L or µg/mL), which is essential for clinical diagnostics and especially valuable when validation and regulatory approval are required.
Additionally, untargeted methods lack standardisation, leading to lower assay reproducibility and often resulting in inconsistent findings across studies. Targeted approaches also typically offer higher specificity and sensitivity, as they are optimised for a defined set of well-characterised analytes. Data interpretation is faster and more cost-effective with targeted approaches.